Oncoshot introduces new cancer clinical trial notification service

In the fast-evolving oncology space, time is of the essence and new developments plus nascent therapies hold the potential to save lives.

In recognition of this, Oncoshot has introduced its new and complimentary cancer clinical trial notification service. This is designed to help busy healthcare professionals manage their time more efficiently and reduce the opportunity costs of not enrolling their patients in promising clinical trials. Partners who have signed up and created their profiles on the Oncoshot platform can now automatically receive regular email updates on the latest cancer clinical trials taking place.

The initiative marks a new level of connectivity and convenience in the clinical trial matching space, which helps to unlock treatment options for patients.

"As a medical oncologist, I work with a hectic schedule and typically do not have the time to manually sift through long lists of cancer clinical trials that may be suitable for my patients. This is why we have created the new service, which complements our trial matching platform by making information more readily available for physicians in Singapore and around the region,"

— Dr Huren Sivaraj, CEO and co-founder of Oncoshot.

Cancer clinical trial matches are identified using the AI-powered Oncoshot platform, which ensures that only the most relevant and carefully curated data is sent to partners. Information in trial notifications is presented in a succinct and easy-to-read format.

If you haven’t already signed up and created a profile at Oncoshot, please do so to activate the new service, which you can find out more about here. The page will also feature updates on new cancer clinical trials.